Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Viavi Solutions Inc. Common Stock trades at $45.43 (market cap $10.85B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Viavi Solutions Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| HALO | VIAV | |
|---|---|---|
Market Cap | $12.58B | $10.85B |
Volume | 2,179,278 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $115.22 | $55.33 |
52-Week Low | $61.63 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $10.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
